An update on small molecules targeting CXCR4 as starting points for the development of anti-cancer therapeutics

CXCR4 and its natural ligand SDF-1α are involved in a number of pathological processes including cancer spread and progression. Herein we provide a comprehensive summary of small molecules recently claimed as CXCR4 antagonists potentially useful for cancer treatment.270